Loading...
| A01864 | Pages: NA | Dec 2021 | 2422 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Global Glycobiology Market
Request Now !Glycobiology is the study of entire biology that includes structure and function of molecules containing carbohydrates (sugar and saccharides) also called as glycans. It is very helpful in biotechnological research and biomedicine. Carbohydrates control almost all the aspects of cellular processing that involves cell-cell interactions, adhesion mechanisms, signalling for growth factors, blood clotting, regulating hormonal activity, and it also directs embryonic development.
Glycobiology market is in the emerging state mainly due to the increase in expenditure by different pharmaceutical companies on R&D. In addition, increase in activities such as drug discovery, government expenditure, technological advancement, public and private investments, and grants and funds for the development of more advanced technologies in the field of R&D. However, factors such as high cost associated with the imaging process, stringent government policies, and lack of skilled technicians impede the market growth.
The global glycobiology market is segmented based on product, application, end-user, and geography. Based on product, the market is classified into reagents, instruments, kits, and enzymes. Reagents are further sub-segmented into Monosaccharides, Glycoproteins, Oligosaccharides, and others. Instruments are further sub-divided into HPLC, antibody arrays, lectin arrays, MALDI-TOF, mass spectroscopy, and others. Kits are further sub-segmented into glycan release kits, glycan labeling kits, glycan purification kits, and others. Enzymes are further sub-classified into neuraminidases, glycosyltransferases, glycosidases, and others. Based on application, it is categorized into drug discovery and development, immunology, diagnostics, oncology, and others. Based on end-user, the market is classified into Pharmaceutical and Biotechnology Companies and research laboratories. The market is analyzed on the basis of four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.
Product launch, collaboration & merger, and acquisition are the key strategies adopted by market players. Agilent Technologies acquired Seahorse Bioscience in September 2015.
Comprehensive competitive analysis and profiles of major market players such as Agilent Technologies, Bruker Corp., Waters Corp., Thermo Fisher Scientific, Takara Bio, Merck, Shimadzu Corp, Prozyme Inc., New England Biolabs, and Danaher Corp. are also provided in the report.
Key Market Benefits:
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
